RT Journal Article
SR Electronic
T1 A Human-Pathogen SEIR-P Model for COVID-19 Outbreak under different Intervention scenarios in Kenya
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.15.20102954
DO 10.1101/2020.05.15.20102954
A1 Ojiambo, Viona
A1 Kimathi, Mark
A1 Mwalili, Samuel
A1 Gathungu, Duncan
A1 Mbogo, Rachel W.
YR 2020
UL http://medrxiv.org/content/early/2020/05/29/2020.05.15.20102954.abstract
AB This work describes the mathematical modelling and dynamics of a novel Coronavirus disease 2019 (COVID-19) in Kenya. The mathematical model assumes Human-Human infection as well as Human-Pathogen interaction. Using the SEIR (Susceptible-Exposed-Infected-Recovered) compartmental model with additional component of the pathogen,we simulated the dynamics of COVID-19 outbreak and impact of different control measures. The resulting system of ordinary differential equations (ODEs) are directly solved using a combination of fourth and fifth-order Runge-Kutta methods. Simulation results indicate that non-pharmaceutical measures such as school closure, social distancing and movement restriction emphatically flatten the epidemic peak curve hence leading to a smaller number of overall disease cases.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study is a mathematical research that can be used to advice policy makers on impact of the Non-Pharmaceutical Interventions on the spread of COVID-19. The study is done by mathematicians but not clinicians.Funding StatementNo external funding was received for this publicationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study is mathematical and does not require an IRB bodyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support findings of this study is available from the corresponding author upon request.